Works matching IS 14765810 AND DT 2023 AND VI 21 AND IP 2
Results: 21
The animal's microbiome and cancer: A translational perspective.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 166, doi. 10.1111/vco.12892
- By:
- Publication type:
- Article
Toosendanin‐induced apoptosis of CMT‐U27 is mediated through the mitochondrial apoptotic pathway.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 315, doi. 10.1111/vco.12889
- By:
- Publication type:
- Article
A retrospective study of canine oral extramedullary plasmacytoma over a 15‐year period (July 2004–July 2019): Treatment, histologic parameters and clinical outcomes.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 302, doi. 10.1111/vco.12888
- By:
- Publication type:
- Article
Prevalence and anatomopathological characterization of cutaneous squamous cell carcinomas with regional and distant metastases in dogs and cats: 20 cases (1985–2020).
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 291, doi. 10.1111/vco.12887
- By:
- Publication type:
- Article
Regulation of programmed death ligand 1 expression by interferon‐γ and tumour necrosis factor‐α in canine tumour cell lines.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 279, doi. 10.1111/vco.12886
- By:
- Publication type:
- Article
Ultrasound‐guided core needle biopsy in dogs with thyroid carcinoma.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 349, doi. 10.1111/vco.12895
- By:
- Publication type:
- Article
Calculation of dose intensity and comparison of published methods using a cohort of canine T‐cell lymphoma patients undergoing CHOP‐based chemotherapy.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 339, doi. 10.1111/vco.12894
- By:
- Publication type:
- Article
Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinna: A multi‐institutional retrospective study.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 332, doi. 10.1111/vco.12893
- By:
- Publication type:
- Article
Chronic adrenergic stress and generation of myeloid‐derived suppressor cells: Implications for cancer immunotherapy in dogs.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 159, doi. 10.1111/vco.12891
- By:
- Publication type:
- Article
A relatively high proportion of dogs with small apocrine gland anal sac adenocarcinoma (AGASACA) primary tumours present with locoregional lymph node metastasis.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 327, doi. 10.1111/vco.12890
- By:
- Publication type:
- Article
Polymorphism of glutathione S‐transferase P1 of dogs with mammary tumours.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 270, doi. 10.1111/vco.12885
- By:
- Publication type:
- Article
Tumour necrosis factor stimulated gene 6 intrinsically regulates PD‐L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 255, doi. 10.1111/vco.12884
- By:
- Publication type:
- Article
Canine squamous cell carcinoma: Electrochemotherapy association with surgery and correlation with overall survival.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 240, doi. 10.1111/vco.12882
- By:
- Publication type:
- Article
Defining the relevance of surgical margins. Part two: Strategies to improve prediction of recurrence risk.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 145, doi. 10.1111/vco.12881
- By:
- Publication type:
- Article
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 200, doi. 10.1111/vco.12876
- By:
- Publication type:
- Article
Frontal sinus carcinoma in forty‐one dogs (2001–2022).
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 231, doi. 10.1111/vco.12880
- By:
- Publication type:
- Article
Establishment of a BRAF V595E‐mutant canine prostate cancer cell line and the antitumor effects of MEK inhibitors against canine prostate cancer.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 221, doi. 10.1111/vco.12879
- By:
- Publication type:
- Article
Sentinel lymph node mapping with computed tomography lymphography for mast cell tumours and a comparison between regional and sentinel lymph node histological status: Sixty‐two cases.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 208, doi. 10.1111/vco.12878
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 1, doi. 10.1111/ddg.15132
- Publication type:
- Article
Feline primary nonhematopoietic malignant liver tumours: A multicenter retrospective study (2000–2021).
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 191, doi. 10.1111/vco.12874
- By:
- Publication type:
- Article
Evaluation of serum interleukin 2 receptor and beta‐2‐microglobulin as prognostic factors for canine lymphoma: A pilot study.
- Published in:
- Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 184, doi. 10.1111/vco.12873
- By:
- Publication type:
- Article